FAS and cancer: As shown in Fig. 2a, the expression pattern of FAS-AS1 was inconsistent in different cancers, as it might be significantly upregulated in acute myeloid leukemia (LAML) while downregulated in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC).